Lupus Erythematosus, Cutaneous

3 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Treatments and conditions

Lupus Erythematosus, Cutaneous
Treatment and conditionWhere it standsTrials
DB-2304 + Placebo for lupus erythematosus, cutaneousPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
DB-2304 + Placebo + Prednisone for lupus erythematosus, cutaneousPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lenalidomide for lupus erythematosus, cutaneousTrial registered, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.